SLRN Nilai Total Aset Perusahaan Acelyrin Inc.

Acelyrin, Inc. (SLRN) business development relies on the efficacy of isokibep in treating arthritis and psoriasis. This chart reflects an asset value of 566.98, which is critical amid program reductions following the failure of its primary anti-inflammatory project and a fierce struggle for liquidity. Meanwhile, the company is developing therapies for dermatological diseases that guarantee long-term revenue through lifelong medication adherence.

SLRN (Acelyrin, Inc.) riwayat Total Aset Perusahaan saka 21.02.2024 nganti 31.05.2025

Rincian analitis lan laporan data perusahaan ACELYRIN, Inc. (SLRN)

- kuotasi lan prakiraan analis:
Kurs saham acelyrin.com|SLRN - Bagan rega target
- data kapitalisasi pasar:
Biji pasar ACELYRIN Inc.|SLRN - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi Saham ACELYRIN|SLRN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku acelyrin.com|SLRN - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Acelyrin, Inc.|SLRN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas ACELYRIN Inc.|SLRN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ACELYRIN Inc.|SLRN - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan ACELYRIN
Pambiji fundamental:Acelyrin, Inc.

This indicator, calculated by reversing the return on assets ratio, reflects the total value of resources and liabilities of Acelyrin, Inc. (SLRN), allowing investors to track the capitalization dynamics of the asset base. Growth in total assets confirms the expansion of the company's financial potential to develop its pipeline of drugs against immune pathologies, although an excessive increase in this metric may signal inefficient capital management.

Pesaing wigati

Total Aset Bisnis HLN|Aset Agregat Perusahaan Kenvue|Verona Pharma PLC - Nilai Total Aset Perusahaan|Total Aset Perusahaan MENS|LGND (Ligand Corp) - Nilai Agregat Aset|Total Aset Perusahaan AMRX (Amneal Pharmaceuticals)|Total Aset Perusahaan perrigo.com PRGO|ALVO - Aset Agregat Perusahaan|Nilai Agregat Aset LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Total Aset Perusahaan|Total Aset Perusahaan amphastar.com|Gunggung Aset Perusahaan PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Nilai Agregat Aset|Aset Agregat Perusahaan Theravance TBPH|Aquestive Corp (AQST) - Aset Perusahaan|SCPH: Gunggung Aset Perusahaan|Tectonic Therapeutic, Inc. - Aset Agregat Bisnis|TNXP: Total Aset Perusahaan|China SXT Pharmaceuticals, Inc. - Nilai Agregat Aset|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Aset Perusahaan|Aset Perusahaan BioHarvest Sciences Inc BHST|Aset Agregat Perusahaan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Nilai Agregat Aset|Total Aset Perusahaan ENTX (Entera Bio)|Total Aset Perusahaan MindWalk Holdings, Inc. HYFT|ABVC BioPharma Inc - Total Aset Perusahaan|Cumberland Corp (CPIX) - Gunggung Aset Perusahaan|QNTM: Total Aset Perusahaan|Aset Perusahaan fibrogen.com (FGEN)|Aset Agregat Perusahaan Telomir Pharmaceuticals, Inc.|Aset Agregat Perusahaan RANI|Gunggung Aset Perusahaan SNYR (Synergy CHC Corp)|RLYB - Aset Perusahaan|Aset Agregat Perusahaan Lexaria Bioscience Corp. LEXX|Nilai Agregat Aset PULM|Pheton - Total Aset Perusahaan|Gunggung Aset Perusahaan Aptorum Group Limited APM|Lyra Therapeutics, Inc (LYRA) - Aset Agregat Perusahaan|Total Aset Bisnis IBO|Gunggung Aset Perusahaan TNFA|YCBD: Nilai Agregat Aset|Total Aset Perusahaan PRFX|Gunggung Aset Perusahaan altamiratherapeutics.com|Aset Agregat Perusahaan Lipella LIPO|OPTN: Total Aset Bisnis|Pieris Pharmaceuticals - Total Aset Perusahaan|procapsgroup.com (PROC) - Gunggung Aset Perusahaan|PTPI (Petros Pharmaceuticals, Inc.) - Gunggung Aset Perusahaan|QLI - Gunggung Aset Perusahaan|Aset Agregat Perusahaan TFF Pharma